These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4651418)

  • 1. Classification of the mycobacteria in relation to clinical significance.
    Marks J
    Tubercle; 1972 Dec; 53(4):259-64. PubMed ID: 4651418
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differentiation of slow-growing scotochromogenous mycobacteria].
    Schröder KH; Pfirrmann K; Töpfer M; Hoff K
    Zentralbl Bakteriol Orig; 1971; 216(2):228-38. PubMed ID: 5551866
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study on slow growing chromogenic (Runyon's group II) mycobacteria].
    Pattyn SR; Hermans-Boveroulle MT; van Ermengem J
    Zentralbl Bakteriol Orig; 1968; 207(4):509-16. PubMed ID: 5742981
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mycobacteria with pink pigment].
    Korsak T; Boisvert H
    Ann Inst Pasteur (Paris); 1972 Jan; 122(1):31-41. PubMed ID: 5040221
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiology and classification of mycobacteria.
    Eisenstadt J; Hall GS
    Clin Dermatol; 1995; 13(3):197-206. PubMed ID: 8521362
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical mycobacteria isolated from diagnostic material.
    Hajós K; Juhász P
    Acta Microbiol Acad Sci Hung; 1970; 17(4):371-9. PubMed ID: 4998386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methods for identification of rhodochrous bacterial complex].
    Mandler F; Tarricone C
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):292-8. PubMed ID: 1016582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic key to mycobacteria encountered in clinical laboratories.
    Wayne LG; Doubek JR
    Appl Microbiol; 1968 Jun; 16(6):925-31. PubMed ID: 4874455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on MOTT bacilli (Mycobacteria other than tubercle bacilli).
    Byrne J; Conalty ML
    J Ir Med Assoc; 1970 Mar; 63(393):91-8. PubMed ID: 4190045
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin).
    Tsukamura M
    Microbiol Immunol; 1986; 30(9):931-3. PubMed ID: 3467156
    [No Abstract]   [Full Text] [Related]  

  • 11. A new practical classification of the mycobacteria.
    Marks J
    J Med Microbiol; 1976 Aug; 9(3):253-61. PubMed ID: 822166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowly growing scotochromogenic mycobacteria isolated from a bovine nodular thelitis lesion.
    Shimizu K; Tsukamura M
    Jpn J Microbiol; 1974 May; 18(3):259-61. PubMed ID: 4427399
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifabutine minimum inhibitory concentrations (MICs) for non-tuberculous mycobacteria in liquid medium by a radiometric method.
    Fadda G; Zanetti S; Enrico P; Foddai G
    J Chemother; 1989 Jul; 1(4 Suppl):218-20. PubMed ID: 16312376
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.
    Tsukamura M
    Microbiol Immunol; 1983; 27(12):1129-32. PubMed ID: 6587177
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the taxonomy of the genus Mycobacterium. I. Classification of fast growing mycobacteria].
    Käppler W
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):311-9. PubMed ID: 5756630
    [No Abstract]   [Full Text] [Related]  

  • 16. Methods for determining the antimicrobial susceptibility of mycobacteria.
    Alcaide F; Esteban J; González-Martin J; Palacios JJ
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):529-535. PubMed ID: 27236235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epsilometer test for determining in-vitro activity of tigecycline against rapidly growing mycobacteria from central Saudi Arabia.
    Al-Ateah SM; Omrani AS; Bakheshwain SM
    Saudi Med J; 2013 May; 34(5):542-3. PubMed ID: 23677274
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility.
    Collins CH; Yates MD; Uttley AH
    J Hyg (Lond); 1985 Dec; 95(3):619-21. PubMed ID: 2936800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility testing for Mycobacterium sp.
    Blanco-Ruano D; Roberts DM; Gonzalez-Del-Rio R; Álvarez D; Rebollo MJ; Pérez-Herrán E; Mendoza A
    Methods Mol Biol; 2015; 1285():257-68. PubMed ID: 25779321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic macrolide resistance in rapidly growing mycobacteria.
    Nash KA; Andini N; Zhang Y; Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3476-8. PubMed ID: 17005837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.